BioCentury
ARTICLE | Company News

MorphoSys, Novartis deal

July 13, 2009 7:00 AM UTC

MorphoSys AG (Xetra:MOR), Martinsried, Germany Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Antibodies The partners' 2007 antibody deal will now run until 2017, after Morphosys met ...